ArticleBMC psychiatry2025
Psychometric evaluation of the Persian version of the Beliefs About Voices Questionnaire: revised in patients with schizophrenia spectrum disorders.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Beliefs About Voices Questionnaire-Revised (BAVQ-R) is a widely used measure in research and clinical settings designed to assess beliefs about auditory hallucinations and the corresponding response styles. Despite its common usage, the psychometric properties of the BAVQ-R are understudied. This study aimed to contribute to this gap in the literature by examining the psychometric properties of the Persian version of the BAVQ-R in Iran.
methodA total of 298 patients diagnosed with Schizophrenia Spectrum Disorder (aged 19–50 years; M = 37.32, SD = 1.14; 85.23% male) were recruited from Razi Hospital in Tehran. Participants completed the BAVQ-R alongside self-report measures (e.g., the Beck Depression Inventory-II [BDI-II] and the Schizophrenia Quality of Life Scale [SQLS]) and underwent interview-based assessments (e.g., the Psychotic Symptom Rating Scales [PSYRATS] and the Calgary Depression Scale for Schizophrenia [CDSS]).
resultsA confirmatory factor analysis supported a 31-item four-factor model comprising two belief subscales (Malevolence/Omnipotence and Benevolence) and two response subscales (Resistance and Engagement), with excellent model fit indices (CFI = 0.99, TLI = 0.99, RMSEA = 0.042). The subscales demonstrated high internal consistency (Cronbach’s α and McDonald’s ω = 0.91–0.95) and correlated in theoretically consistent ways with external constructs (e.g., measures of hallucinations, delusions, depression, and quality of life).
conclusionFindings suggest that the Persian BAVQ-R is a reliable and valid instrument for assessing beliefs about voices and response styles in Iranian patients with Schizophrenia Spectrum Disorder. These findings support its use in both research and clinical settings and suggest avenues for further research to explore its applicability across different populations and settings. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.